Back
Cellectis SA Vs. Monopar Therapeutics Industry Stock Comparison
Sell
48
CLLS
Cellectis SA
Last Price:
1.71
Seasonality Move:
-8.86%
Buy
75
MNPR
Monopar Therapeutics
Last Price:
31.00
Seasonality Move:
35.55%
Sell
48
Cellectis SA (CLLS)
is a Sell
Is Cellectis SA a Buy, Sell or Hold?
- The current Cellectis SA [CLLS] share price is $1.71. The Score for CLLS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- CLLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy, Sell or Hold?
- The current Monopar Therapeutics [MNPR] share price is $30.68. The Score for MNPR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- MNPR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CLLS Stock Price Chart
What is Cellectis SA's stock price today?
-
The Cellectis SA share price today is $1.71
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLLS is experiencing selling pressure, which indicates risk of future bearish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $30.68
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
CLLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 34.96 | Sell |
| Chaikin Money Flow: | -41320 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.82 - 2.04) | Sell |
| Bollinger Bands (100): | (1.86 - 2.24) | Sell |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.92 | Buy |
| Relative Strength Index (14 RSI): | 76.63 | Buy |
| Chaikin Money Flow: | 62338 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.5 - 24.7) | Buy |
| Bollinger Bands (100): | (1.59 - 18.41) | Buy |
CLLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.86 | Sell |
| 20-day SMA: | 1.93 | Sell |
| 50-day SMA: | 1.9 | Sell |
| 200-day SMA: | 2.28 | Sell |
| 8-day EMA: | 1.82 | Sell |
| 20-day EMA: | 1.89 | Sell |
| 50-day EMA: | 1.94 | Sell |
| 200-day EMA: | 2.19 | Sell |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.74 | Buy |
| 20-day SMA: | 22.43 | Buy |
| 50-day SMA: | 16.57 | Buy |
| 200-day SMA: | 6.79 | Buy |
| 8-day EMA: | 25.62 | Buy |
| 20-day EMA: | 22.75 | Buy |
| 50-day EMA: | 17.67 | Buy |
| 200-day EMA: | 9.07 | Buy |
Cellectis SA Earnings Growth & CLLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.79 per share, and a decrease next year of $0.06 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.58 per share, and a decrease next year of $0.91 per share.
Cellectis SA Technical Analysis
| Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics Technical Analysis
| Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||